582 Companies
Futura Medical plc is a pharmaceutical company which specializes in researching and developing drugs and medical devices for consumer healthcare markets, with a focus on sexual health and pain reli...
Futura Medical plc Annual Report 2023Arizona-based HTG Molecular Diagnostics, Inc. is a life sciences company with a precise focus on medicine. According to their website, the company offers a range of instruments, consumables, and so...
HTG Molecular Diagnostics, Inc. Annual Report 2021French clinical-stage biotech firm Cellectis S.A. is developing immuno-oncology treatments using gene-edited T-cells that express chimeric antigen receptors. The company is working on multiple prod...
Cellectis S.A. Annual Report 2021France-based biopharmaceutical firm Genfit S.A. has made significant strides in the development of drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's f...
GENFIT S.A. Annual Report 2023Choice Properties Real Estate Investment Trust is a prominent real estate investment company in Canada that specializes in owning, managing, and developing commercial properties like retail centers...
Choice Properties REIT Annual Report 2023Sydney-based biopharmaceutical firm, Kazia Therapeutics Limited, has been making strides in the development of anti-cancer drugs. Its leading development candidate, Paxalisib, is a brain-penetrant ...
Kazia Therapeutics Limited Annual Report 2023Avenue Therapeutics, a New York-based specialty pharmaceutical firm, is currently focused on developing and bringing revolutionary products to market for use in the acute/intensive care hospital se...
Avenue Therapeutics, Inc. Annual Report 2023With a focus on serving the needs of expectant and new mothers, Destination Maternity Corporation is a leading retailer of maternity clothing. The company's product offerings include a wide range o...
Destination Maternity Corporation Annual Report 2023Myovant Sciences is a healthcare company dedicated to revolutionizing women's and men's healthcare with its lead product candidate, relugolix. This once-daily, oral GnRH receptor antagonist has had...
Myovant Sciences Ltd. Annual Report 2021NantKwest is a clinical-stage immunotherapy company that is focused on utilizing the innate immune system to treat cancer and infectious diseases. The company is a leading producer of clinical dose...
NantKwest, Inc. Annual Report 2018Intercept Pharmaceuticals Targets Commercialization of Breakthrough Therapeutics for Non-Viral Liver Diseases Intercept Pharmaceuticals, Inc., a leading US biopharmaceutical company, is focused on...
Intercept Pharmaceuticals Annual Report 2021Oyster Point Pharma is a clinical-stage biopharmaceutical company that aims to develop and commercialize first-in-class pharmaceutical therapies for ocular surface diseases. The company's lead cand...
Oyster Point Pharma Inc Annual Report 2020Actinogen Medical is a biotechnology company that is listed on ASX and specializes in developing innovative therapies for neurological diseases such as those associated with dysregulated brain cort...
Actinogen Medical Annual Report 2023Chiasma, a biopharmaceutical company, is dedicated to developing and commercializing oral therapies to improve the lives of patients suffering from rare and severe chronic diseases. By utilizing it...
Chiasma, Inc. Annual Report 2019Proteomics International is a medical technology company that specializes in proteomics, the study of proteins. The company has over 16 years of experience providing analytical services on a fee-fo...
Proteomics International Annual Report 2023